I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Camrelizumab plus famitinib in previously chemo-immunothera..:
Ren, Shengxiang
;
Xiong, Anwen
;
Yu, Jia
...
Cancer Immunology, Immunotherapy. 73 (2024) 7 - p. , 2024
Link:
https://doi.org/10.1007/s00262-024-03715-4
RT Journal T1
Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study
UL https://suche.suub.uni-bremen.de/peid=cr-10.1007_s00262-024-03715-4&Exemplar=1&LAN=DE A1 Ren, Shengxiang A1 Xiong, Anwen A1 Yu, Jia A1 Wang, Xicheng A1 Han, Baohui A1 Pan, Yueyin A1 Zhao, Jun A1 Cheng, Yufeng A1 Hu, Sheng A1 Liu, Tianshu A1 Li, Yalun A1 Cheng, Ying A1 Feng, Jifeng A1 Yi, Shanyong A1 Gu, Shanzhi A1 Gao, Shegan A1 Luo, Yongzhong A1 Liu, Ying A1 Liu, Caigang A1 Duan, Huijie A1 Wang, Shuni A1 Yang, Xinfeng A1 Fan, Jia A1 Zhou, Caicun PB Springer Science and Business Media LLC YR 2024 SN 1432-0851 JF Cancer Immunology, Immunotherapy VO 73 IS 7 LK http://dx.doi.org/https://doi.org/10.1007/s00262-024-03715-4 DO https://doi.org/10.1007/s00262-024-03715-4 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)